IDEXX Laboratories EVP Sells $1.8M in Stock

Insider selling represents an 11.92% decrease in executive's ownership stake

Published on Feb. 27, 2026

Got story updates? Submit your updates here. ›

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Executive Vice President Nimrata Hunt sold 2,693 shares of the company's stock for a total transaction of $1,781,527.22. The sale represents an 11.92% decrease in Hunt's ownership stake, which now stands at 19,899 shares valued at $13,163,984.46.

Why it matters

Insider transactions, especially sales, can provide insights into management's views on a company's prospects. While a single transaction does not necessarily indicate a broader trend, ongoing insider selling can sometimes signal potential concerns or a lack of confidence in a company's future performance.

The details

The stock sale took place on Thursday, February 26th, at an average price of $661.54 per share. Following the transaction, Hunt continues to directly own 19,899 shares in IDEXX Laboratories.

  • The stock sale occurred on Thursday, February 26th, 2026.

The players

Nimrata Hunt

Executive Vice President of IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc.

A global developer, manufacturer and provider of diagnostic products and services primarily for the animal health, water testing and food safety markets.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

This insider sale, while not necessarily indicative of broader concerns, is worth monitoring as part of a holistic view of IDEXX Laboratories' performance and management's confidence in the company's future prospects.